slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 34,951-34,980
Pages 10,126
Rows per page 30
Component
34,951-34,980 of 303,780
76
The slide distinguishes between standard LTI and exceptional remuneration using color coding.Kering | ESG Presentation Deck | 79 slides · Kering
Conference presentation Investor relations 2 hits
77
The slide distinguishes between standard LTI and Exceptional remuneration using color coding.Kering | ESG Presentation Deck | 79 slides · Kering
Conference presentation Investor relations 2 hits
78
The slide outlines the specific financial and operational constraints for the company's share buyback program.Kering | ESG Presentation Deck | 79 slides · Kering
Conference presentation Investor relations 2 hits
01
Kymera | Investor Day Presentation Deck | 105 slidesKymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations Beat · Attention2 hits
05
The slide uses a 3-step process diagram to illustrate the biological mechanism of protein degradation.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations Beat · Interest2 hits
21
Includes a mechanism of action diagram, a market data table, and a summary of limitations of current therapies.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 2 hits
22
Data shows significant upregulation of IRAK4 in lesional skin compared to healthy controls across multiple cell types and measurement methods.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 2 hits
30
Data shows mean percentage change from baseline for various cytokines (IFNy, IL1b, IL6, IL8, IL10, IL12, IL17, TNFa).Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 2 hits
32
SAD = Single Ascending Dose; AE = Adverse Event; SAE = Serious Adverse Event.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 2 hits
35
Data shows high efficacy at lower doses with a plateau effect observed at 100mg.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 2 hits
36
The slide compares IRAK4 reduction percentages across two cell types (lymphocytes and monocytes) at Day 7 and Day 14 for various dosage groups.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 2 hits
40
Data shows dose-dependent reduction in cytokine levels compared to placebo, correlated with IRAK4 degradation percentages.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 2 hits
49
Kymera | Investor Day Presentation Deck | 105 slidesKymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 2 hits
54
The slide demonstrates synergistic efficacy of KT-413 across three different combination therapies.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 2 hits
58
Kymera | Investor Day Presentation Deck | 105 slidesKymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 2 hits
67
Kymera | Investor Day Presentation Deck | 105 slidesKymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 2 hits
79
The slide uses a biological mechanism diagram to explain the experimental results shown in the Western blots.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations Loop · Cost Of Inaction2 hits
86
The slide uses a visual metaphor of a 'wedge' expanding the druggable portion of the human proteome.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 2 hits
87
Uses a three-column structure to categorize target classes and corresponding TPD solutions (Heterobifunctional Degraders, Molecular Glues).Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 2 hits
88
The slide uses a list-based structure to detail technical capabilities, with a sidebar legend explaining target types.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 2 hits
89
The chart uses dot size to represent abundance and color to represent different ligases/targets across tissue types.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 2 hits
94
The table demonstrates a clear progression in optimization from Degrader 1 to Degrader 4, particularly in oral bioavailability (F%) across species.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 2 hits
105
Kymera | Investor Day Presentation Deck | 105 slidesKymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations Beat · Action2 hits
15
Nauticus | SPAC Presentation Deck | 41 slidesNauticus | SPAC Presentation Deck | 41 slides · Nauticus Robotics
Pitch deck Investment bank Loop · Cost Of Inaction2 hits
31
The slide presents unit economics and annual projections for a single robot unit.Nauticus | SPAC Presentation Deck | 41 slides · Nauticus Robotics
Pitch deck Investment bank Beat · Business Model2 hits
01
Oak Street Health | Investor Presentation Deck | 27 slidesOak Street Health | Investor Presentation Deck | 27 slides · Oak Street Health
Pitch deck Investor relations 2 hits
17
The slide uses a dual-column layout to contrast location strategy (data-driven maps) with operational standardization (photos and bulleted benefits).Oak Street Health | Investor Presentation Deck | 27 slides · Oak Street Health
Pitch deck Investor relations 2 hits
18
The slide uses a dual-column layout: the left side details acquisition channels (outreach, marketing, partnerships), and the right side illustrates the patient conversion funnel/journey.Oak Street Health | Investor Presentation Deck | 27 slides · Oak Street Health
Pitch deck Investor relations 2 hits
22
The slide uses a two-column layout with primary strategic pillars on the left and detailed tactical initiatives on the right.Oak Street Health | Investor Presentation Deck | 27 slides · Oak Street Health
Pitch deck Investor relations 2 hits
11
The slide uses a matrix structure to define market segments, value propositions, and competitive positioning.Skillsoft | Investor Presentation Deck | 39 slides · Skillsoft
Pitch deck Investor relations Beat · Solution2 hits